🇺🇸 FDA
Patent

US 6676941

Antibody conjugate formulations for selectively inhibiting VEGF

expired A61KA61K2039/505A61K39/3955

Quick answer

US patent 6676941 (Antibody conjugate formulations for selectively inhibiting VEGF) held by The Board of Regents of the University of Texas System expires Mon Jan 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jan 13 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
68
CPC classes
A61K, A61K2039/505, A61K39/3955, A61K47/6811, A61K47/6815